References
- Rodgers G M, Taylor R N, Roberts J M. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–14
- Taylor R N, Musci T J, Kuhn R W, Roberts J M. Partial characterization of a novel growth factor from the blood of women with preeclampsia. J Clin Endocrinol Metab 1990; 70: 1285–91
- Musci T J, Roberts J M, Rodgers G M, et al. Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am J Obstet Gynecol 1988; 159: 1146–51
- Taylor R N, Heilbron D C, Roberts J M. Growth factor activity in the blood of women in whom preeclampsia develops is elevated from early pregnancy. Am J Obstet Gynecol 1990; 163: 1839–44
- Keith J C, Jr, Rowles T K, DiLorenzo K, Mishra S, Mishra H P. Tumor necrosis factor-a may mediate maternal serum cytotoxicity during preeclampsia. J Perinatol 1993; 13: 417–8
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55–63
- Tabibzadeh S. Human endometrium: an active site of cytokine production and action. Endocrine Rev 1991; 12: 272–90
- Jaattela M, Kuusela P, Saksela. Demonstration of tumor necrosis factor in human amniotic fluids and supernatants of placental and decidual tis. Lab Invest 1988; 58: 48–52
- Ying L, Matsuzaki N, Masuhiro K, Kameda T, et al. Trophoblast derived TNFCY induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6 receptor-dependent system in the normal human trophoblasts. J Clin Endocrinol Metab 1992; 74: 184–91
- Schafer A, Pauli G, Friedman W, Dudenhausen V. Human choriogonadotropin (HCG) and human placental lactogen (hPL) inhibit interleukin-2 (IL-2) and increase interleukin-1b (IL-1b), –6 (IL-6) and tumor necrosis factor (TNFα) expression in monocyte cultures. J Perinat Med 1992; 20: 233–40
- Greer I A, Haddad N G, Dawes J, Johnstone F D, Calder A A. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989; 96: 978–82
- Varga P J, Szereday Z, Artner A, Szekeres-Bartho J. Early pregnancy loss, premature and low birth weight delivery, and increased maternal lymphocyte cytotoxicity. Am J Reprod Immunol Microbiol 1989; 19: 136–40
- VanAssche F A, Spitz B, Hanssens M, Pijnenborg R, Bosteels J. Prostacyclin and thromboxane in pregnancy. Cur Topics Obstet Gynecol 1992; 2: 27–31
- Keith J C, Jr, Spitz B, VanAssche F A. Thromboxane synthetase inhibition as a new therapy for preeclampsia: Animal and human studies minireview. Prostaglandins 1993; 45: 3–13
- Foegh M L, Hartmann D P, Rowles J R, . Leukotrienes, thromboxane, and platelet activating factor in organ transplantation. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, P Ramwell, et al. Raven Press, New York 1987; v 17: 140–6